Nichole Tanner to Humans
This is a "connection" page, showing publications Nichole Tanner has written about Humans.
Connection Strength
1.019
-
An Evaluation of Annual Adherence to Lung Cancer Screening in a Large National Cohort. Am J Prev Med. 2022 08; 63(2):e59-e64.
Score: 0.031
-
Guideline-Recommended Lung Cancer Screening Adherence Is Superior With a?Centralized Approach. Chest. 2022 03; 161(3):818-825.
Score: 0.030
-
Mediastinal Staging for Lung Cancer. Chest. 2021 10; 160(4):1552-1559.
Score: 0.029
-
Assessment of Integrated Classifier's Ability to Distinguish Benign From Malignant Lung Nodules: Extended Analyses and 2-Year Follow-Up Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial. Chest. 2021 03; 159(3):1283-1287.
Score: 0.028
-
Improving Inequities in Lung Cancer Screening: Risk Prediction Models and the Potential to Achieve a Great Equalizer Effect. J Thorac Oncol. 2020 11; 15(11):1711-1713.
Score: 0.028
-
Association of Cigarette Type and Nicotine Dependence in Patients Presenting for Lung Cancer Screening. Chest. 2020 11; 158(5):2184-2191.
Score: 0.027
-
Screening Adherence in the Veterans Administration Lung Cancer Screening Demonstration Project. Chest. 2020 10; 158(4):1742-1752.
Score: 0.027
-
Lung Cancer Screening: Patient Selection and Implementation. Clin Chest Med. 2020 03; 41(1):87-97.
Score: 0.027
-
Association of Cigarette Type With Lung Cancer Incidence and Mortality: Secondary Analysis of the National Lung Screening Trial. JAMA Intern Med. 2019 12 01; 179(12):1710-1712.
Score: 0.026
-
Effect of a Rule-in Biomarker Test on Pulmonary Nodule Management: A Survey of Pulmonologists and Thoracic Surgeons. Clin Lung Cancer. 2020 03; 21(2):e89-e98.
Score: 0.025
-
In-person and Telephonic Shared Decision-making Visits for People Considering Lung Cancer Screening: An Assessment of Decision Quality. Chest. 2019 01; 155(1):236-238.
Score: 0.025
-
Shared Decision-making and Lung Cancer Screening: Let's Get the Conversation Started. Chest. 2019 01; 155(1):21-24.
Score: 0.024
-
Standard Bronchoscopy With Fluoroscopy vs Thin Bronchoscopy and Radial Endobronchial Ultrasound for Biopsy of Pulmonary Lesions: A Multicenter, Prospective, Randomized Trial. Chest. 2018 11; 154(5):1035-1043.
Score: 0.024
-
Reviewing Lung Cancer Screening: The Who, Where, When, Why, and How. Clin Chest Med. 2018 03; 39(1):31-43.
Score: 0.023
-
Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease. Am J Respir Crit Care Med. 2017 09 01; 196(5):602-608.
Score: 0.022
-
Response. Chest. 2017 08; 152(2):448-449.
Score: 0.022
-
Invasive Mediastinal Staging in Lung Cancer. Use a Prediction Model or Just Do It? Am J Respir Crit Care Med. 2017 06 15; 195(12):1556-1558.
Score: 0.022
-
Chronic Obstructive Pulmonary Disease as a Lung Cancer Risk: Worth Its Weight in "GOLD". Ann Am Thorac Soc. 2017 03; 14(3):309-310.
Score: 0.022
-
Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation. Chest. 2017 08; 152(2):263-270.
Score: 0.021
-
Primary Care Provider and Patient Perspectives on Lung Cancer Screening. A Qualitative Study. Ann Am Thorac Soc. 2016 11; 13(11):1977-1982.
Score: 0.021
-
The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial. Am J Respir Crit Care Med. 2016 Mar 01; 193(5):534-41.
Score: 0.020
-
Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study. Chest. 2015 Dec; 148(6):1405-1414.
Score: 0.020
-
POINT: Is N2 Disease a Contraindication for Surgical Resection for Superior Sulcus Tumors? Yes. Chest. 2015 Dec; 148(6):1373-1375.
Score: 0.020
-
Rebuttal From Drs Tanner and Silvestri. Chest. 2015 Dec; 148(6):1379-1380.
Score: 0.020
-
What's in a Number? When It Comes to Pulmonary Nodules, It's All About the Number. Am J Respir Crit Care Med. 2015 Nov 15; 192(10):1149-50.
Score: 0.020
-
Racial Differences in Outcomes within the National Lung Screening Trial. Implications for Widespread Implementation. Am J Respir Crit Care Med. 2015 Jul 15; 192(2):200-8.
Score: 0.019
-
Screening for Lung Cancer Using Low-Dose Computed Tomography. Are We Headed for DANTE's Paradise or Inferno? Am J Respir Crit Care Med. 2015 May 15; 191(10):1100-1.
Score: 0.019
-
Screening and early detection efforts in lung cancer. Cancer. 2015 May 01; 121(9):1347-56.
Score: 0.019
-
Convex probe endobronchial ultrasound. Semin Respir Crit Care Med. 2014 Dec; 35(6):636-44.
Score: 0.018
-
Attitudes and beliefs toward lung cancer screening among US Veterans. Chest. 2013 Dec; 144(6):1783-1787.
Score: 0.017
-
Simultaneously diagnosing and staging lung cancer: a win-win for the patient and the health-care system. Chest. 2013 Dec; 144(6):1747-1749.
Score: 0.017
-
Training for linear endobronchial ultrasound among US pulmonary/critical care fellowships: a survey of fellowship directors. Chest. 2013 Feb 01; 143(2):423-428.
Score: 0.016
-
Physician preferences for management of patients with stage IIIA NSCLC: impact of bulk of nodal disease on therapy selection. J Thorac Oncol. 2012 Feb; 7(2):365-9.
Score: 0.015
-
New testing for lung cancer screening. Oncology (Williston Park). 2012 Feb; 26(2):176-82.
Score: 0.015
-
The role of molecular analyses in the era of personalized therapy for advanced NSCLC. Lung Cancer. 2012 May; 76(2):131-7.
Score: 0.015
-
An up to date look at lung cancer screening. Cell Adh Migr. 2010 Jan-Mar; 4(1):96-9.
Score: 0.013
-
Research Priorities for Interventions to Address Health Disparities in Lung Nodule Management: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2023 03 15; 207(6):e31-e46.
Score: 0.008
-
Characteristics of Persons Screened for Lung Cancer in the United States : A Cohort Study. Ann Intern Med. 2022 Nov; 175(11):1501-1505.
Score: 0.008
-
Factors Associated With Smoking Cessation Attempts in Lung Cancer Screening: A Secondary Analysis of the National Lung Screening Trial. Chest. 2023 02; 163(2):433-443.
Score: 0.008
-
Study design for a proactive teachable moment tobacco treatment intervention among patients with pulmonary nodules. Contemp Clin Trials. 2022 Oct; 121:106908.
Score: 0.008
-
Tobacco Treatment Specialist Training for Lung Cancer Screening Providers. Am J Prev Med. 2021 11; 61(5):765-768.
Score: 0.007
-
Response. Chest. 2021 01; 159(1):438-439.
Score: 0.007
-
Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement. Am J Respir Crit Care Med. 2020 10 01; 202(7):e95-e112.
Score: 0.007
-
Occurrence of Discussion about Lung Cancer Screening Between Patients and Healthcare Providers in the USA, 2017. J Cancer Educ. 2020 08; 35(4):678-681.
Score: 0.007
-
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Chest. 2020 07; 158(1):406-415.
Score: 0.007
-
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. J Am Coll Radiol. 2020 Jul; 17(7):845-854.
Score: 0.007
-
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Radiol Imaging Cancer. 2020 05; 2(3):e204013.
Score: 0.007
-
An Evaluation of Diagnostic Yield From Bronchoscopy: The Impact of Clinical/Radiographic Factors, Procedure Type, and Degree of Suspicion for Cancer. Chest. 2020 06; 157(6):1656-1664.
Score: 0.007
-
Safely and Effectively Evaluating Computed Tomography-detected Lung Lesions. Much Work to Be Done. Ann Am Thorac Soc. 2019 11; 16(11):1360-1362.
Score: 0.007
-
Safety and Efficacy of Remimazolam Compared With Placebo and Midazolam for?Moderate Sedation During Bronchoscopy. Chest. 2019 01; 155(1):137-146.
Score: 0.006
-
Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2018 07 15; 198(2):e3-e13.
Score: 0.006
-
Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial. Chest. 2018 07; 154(1):110-118.
Score: 0.006
-
Comparison of Observed Harms and Expected Mortality Benefit for Persons in the Veterans Health Affairs Lung Cancer Screening Demonstration Project. JAMA Intern Med. 2018 03 01; 178(3):426-428.
Score: 0.006
-
Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial. Chest. 2018 09; 154(3):491-500.
Score: 0.006
-
Underuse of Chest Radiography Versus Computed Tomography for Lung Cancer Screening. Am J Public Health. 2017 08; 107(8):1248-1250.
Score: 0.006
-
ATS Core Curriculum 2017: Part IV. Adult Pulmonary Medicine. Ann Am Thorac Soc. 2017 08; 14(Suppl_2):S196-S208.
Score: 0.006
-
Comparing Pulmonary Nodule Location During Electromagnetic Bronchoscopy With Predicted Location on the Basis of Two Virtual Airway Maps at Different Phases of?Respiration. Chest. 2018 01; 153(1):181-186.
Score: 0.006
-
Racial and Ethnic Disparities in Early-Stage Lung Cancer Survival. Chest. 2017 09; 152(3):587-597.
Score: 0.005
-
Implementation of Lung Cancer Screening in the Veterans Health Administration. JAMA Intern Med. 2017 03 01; 177(3):399-406.
Score: 0.005
-
Viewing All the Trees in the Forest: The Importance of Reporting Abnormal Findings on CT Scan When Screening for Lung Cancer. Chest. 2017 03; 151(3):525-526.
Score: 0.005
-
Evaluations of Implementation at Early-Adopting Lung Cancer Screening Programs: Lessons Learned. Chest. 2017 07; 152(1):70-80.
Score: 0.005
-
Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial. Ann Am Thorac Soc. 2016 09; 13(9):1568-74.
Score: 0.005
-
An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice. Am J Respir Crit Care Med. 2015 Oct 01; 192(7):881-91.
Score: 0.005
-
Reply: Lung Cancer Screening: The Balance between Harm and Benefit. Am J Respir Crit Care Med. 2015 May 15; 191(10):1209-10.
Score: 0.005
-
Lung cancer screening. Am J Respir Crit Care Med. 2015 Jan 01; 191(1):19-33.
Score: 0.005
-
Factors that influence physician decision making for indeterminate pulmonary nodules. Ann Am Thorac Soc. 2014 Dec; 11(10):1586-91.
Score: 0.005
-
Construct validity of the Simbionix bronch mentor simulator for essential bronchoscopic skills. J Bronchology Interv Pulmonol. 2014 Oct; 21(4):314-21.
Score: 0.005
-
Outcome of patients with negative and unsatisfactory cytologic specimens obtained by endobronchial ultrasound-guided transbronchial fine-needle aspiration of mediastinal lymph nodes. Cancer Cytopathol. 2015 Feb; 123(2):92-7.
Score: 0.005
-
Assessing the usefulness of 18F-fluorodeoxyglucose PET-CT scan after stereotactic body radiotherapy for early-stage non-small cell lung cancer. Chest. 2014 Aug; 146(2):406-411.
Score: 0.005
-
Response. Chest. 2014 Aug; 146(2):e70.
Score: 0.005
-
The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules. Chest. 2014 Mar 01; 145(3):464-472.
Score: 0.004
-
Diagnostic approach to the solitary pulmonary nodule. Semin Respir Crit Care Med. 2013 Dec; 34(6):762-9.
Score: 0.004
-
The latest generation in flexible bronchoscopes: a description and evaluation. J Bronchology Interv Pulmonol. 2013 Oct; 20(4):357-62.
Score: 0.004
-
The use of convex probe endobronchial ultrasound-guided transbronchial needle aspiration in a pediatric population: a multicenter study. Pediatr Pulmonol. 2014 Aug; 49(8):807-15.
Score: 0.004
-
Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer. Chest. 2011 Dec; 140(6):1550-1556.
Score: 0.004
-
Lung cancer: progress in diagnosis, staging and therapy. Respirology. 2010 Jan; 15(1):44-50.
Score: 0.003
-
A 79-year-old woman with a right paratracheal mass. Chest. 2009 May; 135(5):1384-1388.
Score: 0.003